
Combidex Probably Useful, ODAC Says, But Finds Clinical Trials Unconvincing, Inadequate
Author(s) -
Margot J. Fromer
Publication year - 2005
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000287768.06032.a0
Subject(s) - clinical trial , redux , bisphosphonate , medicine , intensive care medicine , osteoporosis , engineering , aerospace engineering